NEIL3 and gastric adenocarcinoma: The results showed that NEIL3 was only increased in the mutation group in LUSC compared with the non-mutation group, while no significant difference in expression was found in LUAD, COAD, colon adenocarcinoma/rectum adenocarcinoma esophageal carcinoma (COADREAD), stomach and esophageal carcinoma (STES), STAD, UCEC, and bladder urothelial carcinoma (BLCA) (Figure 4A).